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Malaria is a signiﬁcant global burden but after >30 years of effort there is no vaccine
on the market. While the complex life cycle of the parasite presents several challenges,
many years of research have also identiﬁed several mechanisms of immune evasion by
Plasmodium spp. Recent research on malaria, has investigated the programmed cell death-
1 (PD-1) pathway which mediates exhaustion of T cells, characterized by poor effector
functions and recall responses and in some cases loss of the cells by apoptosis. Such
studies have shown exhaustion of CD4+ T cells and an unappreciated role for CD8+ T cells
in promoting sterile immunity against blood stage malaria. This is because PD-1 mediates
up to a 95% reduction in numbers and functional capacity of parasite-speciﬁc CD8+ T
cells, thus masking their role in protection. The role of T cell exhaustion during malaria
provides an explanation for the absence of sterile immunity following the clearance of acute
disease which will be relevant to future malaria-vaccine design and suggests the need for
novel therapeutic solutions. This review will thus examine the role of PD-1-mediatedT cell
exhaustion in preventing lasting immunity against malaria.
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INTRODUCTION
Malaria is a mosquito-borne infectious disease of humans caused
by parasitic protozoans of the genus Plasmodium. There are ﬁve
species that infect humans and annual deaths from themalaria par-
asite Plasmodium falciparum (Pf) alone are estimated at 780,000,
with approximately 225 million clinical infections worldwide
(Schwartz et al., 2012). The Anopheles mosquito, serves as a trans-
mission vector for the parasite. An infected mosquito introduces
sporozoites into the blood or lymph of bitten individuals when
taking a blood meal. These sporozoites then migrate to the host’s
liver, where they begin to invade and multiply. During the ﬁrst
week of infection, sporozoites develop into merozoites and then
exit the hepatocytes to invade red blood cells progressively, result-
ing in massive destruction of red blood cells. This eventually leads
to anemia in infected subjects due to the loss of erythrocyte and
severe symptoms associated with malaria.
Over the last 10 years, more than 40 vaccines were developed
to control the morbidity of malaria which then reached the clini-
cal trial stage (Schwartz et al., 2012). Most of these vaccines were
speciﬁcally designed to target liver or blood stage parasites, the
majority through protection by antibodies and/or CD4+ T cells.
Although some of them showed potent protection at pre-clinical
trials (Schwartz et al., 2012), none to date conferred complete pro-
tection against both clinical and severemalaria. Theonly vaccine to
reach stage 3b, RTS,S/AS01E, showed approximately 50% efﬁcacy
for 18months (Alonso et al., 2005) but immunity was signiﬁcantly
diminished within 4 years (Olotu et al., 2013). Notably, protection
declined over time and with increasing malaria exposure.
To explain why these vaccines have been unsuccessful, it is
important to understand natural immunity against malaria. Per-
haps most informative has been an intensive longitudinal study
of immunity in Malian children and adults (Tran et al., 2013).
In this study, 251 healthy children and adults who were free of
blood-stage Plasmodium infections, by polymerase chain reaction
(PCR), were enrolled just prior to an intense 6-month malaria
season. Subsequent clinical malaria episodes were detected by
weekly active surveillance or self-referral. Asymptomatic infec-
tions were detected by blood-smear microscopy and PCR analysis
of blood collected every 2 weeks for 7 months. These studies
found that while the risk of symptomatic malaria decreased with
increasing age, the risk P. falciparum infections did not change.
This means that despite years of exposure to intense Pf trans-
mission, there was no evidence of acquired, sterile immunity
to the parasite in this population, even as clinical immunity to
blood-stagemalaria was clearly acquired (Tran et al., 2013). Signif-
icantly, this indicates thatwhile anti-malarial immune responses to
protect against symptoms were effectively induced, sterile immu-
nity against the parasite was not acquired in the same time
frame.
NATURALLY ACQUIRED IMMUNITY
The factors that regulate anti-parasite immunity (i.e., those pro-
cesses that kill parasites and reduce parasite biomass in the
body) are not completely understood. For decades it has been
known that antibodies play an important role in protection
against malaria, and it has been assumed that antibody responses
alone can provide sufﬁcient protection to control this disease.
This was predominantly based on studies where the transfer
of IgG from malaria-immune individuals to non-immune indi-
viduals markedly reduced parasite burden (Cohen et al., 1961).
Studies indicating that antibodies protect against malaria have
led to a large-scale effort to develop a B cell targeted vaccine
against malaria, with limited success to date. In endemic set-
tings, memory antibody responses against Plasmodium parasites
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are short-lived and require constant parasite exposure (Crompton
et al., 2010). Furthermore, a year-long study in malaria-endemic
Mali, found that both Pf-speciﬁc memory B cells (MBC) and anti-
body titers increased after acute malaria and then, after 6 months
of decreased Pf exposure, contracted to a point slightly higher
than pre-infection levels (Weiss et al., 2010). Further, the 19-
kDa carboxyl-terminal fragment of merozoite surface protein 1
(MSP119) was a leadingmalaria vaccine candidate, tested in Kenya
which has holoendemic transmission of Pf. In these trials, vaccina-
tion with MSP119 generated very high titers of antibodies, but did
not protect against infection (Ogutu et al., 2009). An evaluation
of this vaccine using an experimental mouse model found that
vaccination with MSP119 generated MSP119-speciﬁc MBC capa-
ble of secreting antibodies in response to the vaccine (MSP119),
but not infection (Wykes et al., 2005). In fact, infection caused
apoptosis of MBC. Subsequent studies showed malarial infections
result in a decrease in the proportion of dendritic cells (DCs) that
expressed the B-cell survival factor, BAFF, resulting in a decreased
ability of these DCs to support MBC survival (Liu et al., 2012).
A review proposes a model of how the parasite may mediate
these effects by direct interaction with B cells and modulation
of the host’s BAFF-immune pathway (Scholzen and Sauerwein,
2013).
CD4+ T cells consist of several helper-subtypes which shape
immune responses against particular pathogens. During malaria,
CD4+ T cell subsets have multiple roles in protection, pathogen-
esis and also escape from immune responses. CD4+ T cells have
been demonstrated to be the major source of both interferon-γ
(IFN-γ) and tumor necrosis factor alpha (TNF-α) during experi-
mental malaria in mice (Muxel et al., 2011) which are implicated
in both protection and pathology of this disease. Studies in
mice infected with Plasmodium chabaudi malaria have shown
that IFN-γ and TNF-α cooperatively induce nitric oxide synthase
expression in the spleen to control peak parasite burden (Jacobs
et al., 1996). Similarly, in humans, early IFN-γ responses to Pf
correlate with better anti-parasite immunity (McCall et al., 2010).
IFN-γ contributes to a vast network of protective responses against
malaria, summarized in McCall and Sauerwein (2010). Of par-
ticular note is a study which investigated the effects of chronic
malaria on MSP1-speciﬁc transgenic CD4+ T cells (Stephens and
Langhorne, 2010). These parasite-speciﬁc T cells were seeded
into Thy1.1 congenic mice which were then infected with 105 P.
chabaudi infected red cells. One half of the mice were treated
with Chloroquine on days 30–34 to clear chronic malaria. After
60 days, ﬂow cytometric analysis of transgenic T cells found
that approximately 25% of memory CD44+IL-7R+ CD4+ T
cells were lost in untreated mice compared to drug-treated mice
which had cleared the infection (Stephens and Langhorne, 2010).
This study highlights that ongoing infections cause a loss of
some parasite-speciﬁc memory T cells capable of protection from
re-infection.
The loss of CD4+ T cells during malaria was perhaps ﬁrst sug-
gested when up to 99% of parasite-speciﬁc T cells labeled with the
ﬂuorescent dye 5-(and -6)-carboxy-ﬂuorescein succinimidyl ester
(CSFE), were found to be deleted only following infection of mice
(Hirunpetcharat and Good, 1998). Subsequent studies also found
deletion of T cells speciﬁc for the malaria vaccine, MSP119 during
malaria infections (Wipasa et al., 2001). Further studies excluded a
role for TNF or Fas pathways but implicated IFN-γ in loss of these
cells (Xu et al., 2002). However, FOXP3-expressing CD4+CD25+
regulatory T cells were also shown to correlate with more rapid
parasite growth in humanmalaria infections (Walther et al., 2005)
which may explain why protective cells subside. Mouse models
also showed IL-10 produced by these cells was responsible for
poor immunity (Couper et al., 2008). Finally, other studies identi-
ﬁed elevated numbers of a highly suppressive subset of regulatory
T cells in patients with severe malaria (Minigo et al., 2009).
The role of CD8+ T cell-mediated immunity against blood-
stage malaria has been largely overlooked, with research being
limited to protection against liver-stage infection, the pathogene-
sis of cerebral malaria (Hafalla et al., 2006) and damage to splenic
architecture (Beattie et al., 2006). This view was adopted because
parasites and infected erythrocytes have no known antigen presen-
tation machinery and therefore T cells supposedly cannot interact
directly with these potential targets (Langhorne et al., 2008). How-
ever, early studies in experimental animal models found that
depletion of CD8+ T lymphocytes during blood stage P. chabaudi
infections, signiﬁcantly delayed clearance of the infection (Podoba
and Stevenson,1991). Other groups showed that naivemice, trans-
fused with CD8+ T cells derived from mice that survived two
successive bouts of lethal P. yoelii infections with drug cure, subse-
quently survived lethal blood stage malaria challenge (Imai et al.,
2010). More recent studies in experimental mouse models have
shown that malaria parasites can parasitize erythroblasts, which
have the capacity to activate CD8+ T cells (Imai et al., 2013).What
has remained unclear is that while these studies showed CD8+ T
cells had potential to protect against blood stage malaria, direct
studies did not ﬁnd a clear role for these cells in protection against
blood stage disease.
PROGRAMMED CELL DEATH 1
Programmed cell death-1 (PD-1) is a member of the extended
family of molecules that are known to down-regulate T cell func-
tion. PD-1 has two known ligands, PD-L1 (B7-H1; Dong et al.,
1999; Freeman et al., 2000) and PD-L2 (B7-DC; Latchman et al.,
2001; Tseng et al., 2001), which both belong to the B7 co-signaling
molecule family. Expression of PD-1 can be observed on T cells,
B cells, natural killer T cells, DCs, and activated monocytes (Keir
et al., 2008). PD-1 is not expressedon restingT cells but is inducible
upon activation (Agata et al., 1996). Functional effects of PD-1
ligation can be observed within a few hours after T cell activation
but PD-1 cell surface protein up-regulation requires 24 h (Chem-
nitz et al., 2004). When PD-1 is engaged simultaneously with T
cell receptor signals, it can trigger an inhibitory signal, although
no signal transduction occurs when PD-1 is cross-linked alone
(Sharpe et al., 2007). In general, interactions between PD-1 on T
cells and its ligand, PD-L1, control the induction andmaintenance
of peripheral T-cell tolerance and negatively regulate proliferation
and cytokine production by T cells during immune responses to
pathogens or cancer (Sharpe et al., 2007).
A main feature of potent immunity against intracellular
pathogens is the development of an optimal T cell response which
shows rapid proliferative potential, low apoptosis and polyfunc-
tionality (Lukens et al., 2008). During acute infections, optimal
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functioning T cells clear the pathogen, eventually leading to devel-
opment of robust memory T cells. Those T cells have the ability
to mount rapid recall response and re-establish polyfunctional
effector mechanisms upon antigen re-exposure (Wherry, 2011). T
cell exhaustion is deﬁned by inferior effector function, sustained
expression of inhibitory receptors (such as PD-1), poor recall
responses and a transcriptional state distinct from that of func-
tional effector ormemory T cells (Wherry, 2011). Inmany chronic
infectious diseases, antigen speciﬁc T cells become functionally
impaired or exhausted. For example, viruses, such as human
immunodeﬁciency virus (HIV) and hepatitis C virus (HCV) have
been shown to induce T cell exhaustion mediated by PD-1 (Day
et al., 2006; Urbani et al., 2006). Signiﬁcantly, blockade of the PD-1
pathway improved immunity (Freeman et al., 2006; Urbani et al.,
2008). PD-1-related exhaustion has also been implicated in other
chronic protozoan infections, such as Leishmaniasis (Liang et al.,
2006; Joshi et al., 2009). Further, the apicomplexan parasite, Tox-
oplasma gondii has been shown to induce PD-1 expression on
CD8+ T cells, but function was restored by experimental blockade
of the PD-1 pathway during chronic murine infections (Bhadra
et al., 2011). Together these data have established T cell exhaus-
tion by PD-1 as a key mechanism in chronicity of infectious
diseases.
EXHAUSTION OF CD4+ T CELLS DURING MALARIA
PD-1 has been implicated in the pathogenesis of malaria. One of
the ﬁrst studies to examine PD-1 expression during malaria used
a mouse model to show PD-1 expression on IL-7Rlo-expressing
CD4+ and CD8+ T cells (Chandele et al., 2011). These PD-1-
expressing cells (especially CD8+ T cells) were almost completely
lost within 30 days of infection (Chandele et al., 2011). The study
did not however measure functional responses to identify T cell
exhaustion. Similarly, subsequent studies showed that PD-1 was
also expressed on CD4+ (Butler et al., 2012; Illingworth et al.,
2013) and CD8+ T cells (Illingworth et al., 2013) in blood of Pf-
infected individuals inMali and Kenya, but no functional evidence
of exhaustion was provided.
To validate these observations, a murine model of blood stage
malaria was adopted to explore the effects of increased expression
of PD-1 and LAG-3 on CD4+ T cells (Butler et al., 2012). The
combined blockade of PD-L1 and LAG-3 inhibitory molecules
with antibodies, during P. yoelii and P. chabaudi malaria in mice
accelerated clearance of parasitemia (Butler et al., 2012). This dual
blockade of PD-L1 and Lag-3 improved CD4+ follicular T helper
cell (TFH) numbers which correlated with enhanced antibody-
mediated immunity (Butler et al., 2012). Moreover, infected mice
treatedwith the anti-malarial drug chloroquine at day 8 and9post-
infection, showed a lower level of CD4+ T cell dysfunction (Butler
et al., 2012). These studies showed that lymphocyte exhaustion
modulated immunity against malaria.
Subsequent studies used mice with a deletion of PD-1 (PD-
1KO) to conclusively determine if PD-1 had a role in modulating
immunity, given that PD-L1 can interact speciﬁcally with both
B7-1 (Butte et al., 2007) and PD-1 (Iwai et al., 2003) to inhibit T
cell activation. P. chabaudi malaria was investigated as this infec-
tion develops into chronic infections. It was shown that PD-1
mediated a reduction in the capacity of parasite-speciﬁc CD4+
T cells to proliferate and secrete IFN-γ and TNF-α during the
chronic phase of malaria (day 35) indicating exhaustion of these
cells (Horne-Debets et al., 2013). However, in contrast to the com-
bined PD-L1/Lag-3 blockade study, no changes to TFH numbers
were observed. One likely explanation for this apparent contradic-
tion is that PD-1 KO mice compared with wild type (WT) mice
had a signiﬁcantly higher proportion of regulatory T follicular
cells (TFR cells; Horne-Debets et al., 2013). TFR cells are known
to be suppressive in vitro and to limit the numbers of TFH cells
and germinal centers (GC) B cells in vivo (Linterman et al., 2011).
Alternatively, since PD-L1 can also interact speciﬁcally with B7-1
to inhibit T cell activation (Butte et al., 2007), this pathway may
control TFH numbers in PD-1 KO mice.
B CELLS AND EXHAUSTION
Antibodies are known to have a key role in controlling blood-stage
infections (Cohen et al., 1961). Investigations into the mechanism
of protection, found mice deﬁcient in mature B cells developed a
chronic relapsing parasitemia, conﬁrming the need for antibodies
to control chronic malaria (von der Weid et al., 1996). For anti-
bodies to be protective, they have to undergo processes of class
switching, somatic mutation, and afﬁnity selection within GC
where antibodies of the highest afﬁnity are generated and selected.
The formation of GC requires TFH which also contribute to B cell
differentiation into plasma and memory cells (Crotty, 2011).
The combined blockade of PD-L1 and LAG-3 increased num-
bers of CD4+ TFH and GC B cells along with higher antibody
titers which contributed to better control of blood stage of malaria
(Butler et al., 2012). In contrast, PD-1 KO mice showed no signif-
icant improvement in numbers of germinal center B cells, plasma
cells or antibody titers (Horne-Debets et al., 2013). The absence
of any improvement in B cell function in PD-1KO mice could
be explained by an absence of improvement in TFH numbers or
inhibitory signals to LAG-3 expressed on B cells (Kisielow et al.,
2005).
EXHAUSTION OF CD8+ T CELLS DURING MALARIA
PD-1-mediated cellular exhaustion has been best associated with
exhaustion of CD8+ T cells. However, as described earlier, a
role for CD8+ T cells in the clearance of blood-stage malaria
is not widely acknowledged although their role in pathogenesis
of cerebral malaria and damage to splenic architecture (Beat-
tie et al., 2006) are known. Critically, PD-1 was recently shown
to mediate a 95% loss in the numbers and functional capac-
ity of parasite-speciﬁc CD8+ T cells during the acute phase
of malaria, which exacerbated the infection leading to chronic
malaria (Horne-Debets et al., 2013). This study examined the
progression of chronic malaria in PD-1 KO mice compared to
WT where 100% of mice develop chronic infections. Interest-
ingly, <30% of the PD-1 KO mice developed chronic infections,
and parasitemia levels in these mice were >100-fold lower than
those in the WT mice. However, depletion of CD8+ T cells
in PD-1 KO mice, increased peak parasitemia by 2-fold and
100% of the PD-1 KO mice developed chronic malaria (Horne-
Debets et al., 2013). Overall, PD-1-mediated 80% reduction in
numbers of tetramer+CD8+CD62L− T cells and 95% reduction
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in capacity of CD8+ cells to proliferate in response to para-
sites, during the chronic phase of malaria (Horne-Debets et al.,
2013). Of particular note is that even though PD-1 KO mice
had more functional CD4+ T cells than WT mice and similar
titers of parasite-speciﬁc antibodies, they still developed chronic
malaria if CD8+ T cells were depleted. Finally, PD-1 KO mice
had more granzyme B-expressing CD8+ T cells than WT mice
suggesting that cytotoxic-killing of infected cells was involved.
These observations highlight the crucial role of CD8+ T cells
in protection against chronic malaria. In contrast, a previous
study had found blockade of PD-L1 augmented experimental
cerebral malaria which is mediated by pathogenic CD8+ T cells
(Hafalla et al., 2012), indicating the pathway protects against
cerebral malaria. The clinical signiﬁcance of these ﬁndings are
highlighted by studies in Kenya which found human CD8+ T cells
from individuals infected with malaria, express PD-1 (Illingworth
et al., 2013). Thus the role of CD8+ T cells requires particular
consideration as it may explain why despite years of exposure
to intense Pf transmission there was no evidence of acquired,
sterile immunity (Tran et al., 2013). It may be that antibod-
ies and CD4+ T cells provide protection against symptomatic
malaria but CD8+ T cells are required for sterile immunity.
Thus with PD-1 mediated exhaustion of CD8+ T cells, ster-
ile immunity is never acquired as recently reported (Tran et al.,
2013).
CONCLUSION
Antibodies and CD4+ T cells are known to protect against blood-
stage Plasmodium spp. infections. However, there is a growing
body of evidence that show that CD8+ T cells have a role in
protection. Furthermore, there is also increasing evidence that
lymphocyte exhaustion mediates loss of protection by CD4+ and
CD8+ T cells. Finally, studies have shown MBC numbers (Weiss
et al., 2010) and antibody (Crompton et al., 2010) titers speciﬁc
for the parasite decline following malarial infections. Accord-
ingly, the likelihood of making a malaria vaccine is declining. The
new frontier may be the development of therapeutics to block
Plasmodium-mediated pathogenesis.
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